期刊文献+

基于结直肠癌微环境特征的免疫检查点抑制药联合治疗策略研究现状 被引量:2

Research status of combined therapies with immune checkpoint inhibitor based on tumor microenvironment characteristics in colorectal cancers
原文传递
导出
摘要 结直肠肿癌(CRC)是常见且致死率高的消化系统肿瘤之一,预后较差。免疫检查点抑制药(ICI)通过增强肿瘤微环境(TME)中免疫细胞对肿瘤细胞的杀伤发挥抗肿瘤作用。尽管ICI在血液肿瘤和部分实体肿瘤病人中已取得较为理想的疗效,但在CRC尤其是转移型CRC(mCRC)中响应率较低。TME中存在的多重物理屏障和免疫抑制因素是ICI的疗效被削弱的关键因素,探索ICI与靶向TME的治疗策略的联合治疗方案对解决ICI在CRC中的低响应率有重要临床意义。本文就CRC的TME特征、ICI在CRC中的应用现状和局限性、靶向TME的ICI增效和获益泛化研究现状作一综述,为精准肿瘤免疫治疗的深入发展提供线索和方向。 The colorectal cancer(CRC)is one of the most common and life-threatening gastrointestinal tumors.The prognostic outcomes of CRC remain to be poor.Immune checkpoint inhibitors(ICI)boost the defence of tumor cells by immune cells in the tumor microenvironment(TME)and thus,exerting anti-tumor effects.Despite that ICI have shown promising benefits in patients with hematologic neoplasms and some solid tumors,the response rate and effectiveness of ICI in patients with CRC,especially metastatic CRC(mCRC)remain low.Multiple physical barriers and immunosuppressive factors in TME are the key factors attenuating the efficacy of ICI.Exploring the combined treatment with ICI targeting TME is of great clinical significance to elevate the response rates of ICI in CRC.The present article is aimed to review the characterization of TME in CRC,the application and limitation of ICI in CRC and the status in research of strategies aimed to synergize and generalize the benefit of ICIs targeting TME.This article provides the clues and direction for the further development of accurate anti-tumor immunotherapies.
作者 张雯婷 胡楠 ZHANG Wen-ting;HU Nan(Tumor Biological Diagnosis and Treatment Center,The Third Affiliated Hospital of Soochow University,Changzhou 213003,Jiangsu Province,China;Department of Pharmacy,The Third Affiliated Hospital of Soochow University,Changzhou 213003,Jiangsu Province,China;Jiangsu Engineering Research Center for Tumor Immunotherapy,Changzhou 213003,Jiangsu Province,China;Institute of Cell Therapy,Soochow University,Changzhou 213003,Jiangsu Province,China;Asthma and Bronchitis Research Center,Changzhou 213003,Jiangsu Province,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2023年第10期1500-1504,共5页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金青年基金资助项目(81801493) 中国博士后科学基金第70批面上基金资助项目(2021M700546) 常州市卫生健康青苗人才基金资助项目(2020105)。
关键词 结直肠肿瘤 肿瘤微环境 免疫检查点抑制药 免疫肿瘤学 colorectal cancer tumor microenvironment immune checkpoint inhibitor immuno-oncology
  • 相关文献

参考文献2

二级参考文献99

  • 1Schwabe RF, Jobin C. The microbiome and cancer. Nat RevCancer 2013; 13: 800-812 [PMID: 24132111 DOI: 10.1038/nrc3610]. 被引量:1
  • 2Dickson RP, Martinez FJ, Huffnagle GB. The role of themicrobiome in exacerbations of chronic lung diseases.Lancet 2014; 384: 691-702 [PMID: 25152271 DOI: 10.1016/S0140-6736(14)61136-3]. 被引量:1
  • 3Kahn SE, Cooper ME, Del Prato S. Pathophysiology andtreatment of type 2 diabetes: perspectives on the past, present,and future. Lancet 2014; 383: 1068-1083 [PMID: 24315620 DOI:10.1016/S0140-6736(13)62154-6]. 被引量:1
  • 4Ogino S, Galon J, Fuchs CS, Dranoff G. Cancer immunology--analysis of host and tumor factors for personalized medicine. NatRev Clin Oncol 2011; 8: 711-719 [PMID: 21826083 DOI: 10.1038/nrclinonc.2011.122]. 被引量:1
  • 5Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driverpassengermodel for colorectal cancer: beyond the usual suspects.Nat Rev Microbiol 2012; 10: 575-582 [PMID: 22728587 DOI:10.1038/nrmicro2819]. 被引量:1
  • 6Signat B, Roques C, Poulet P, Duffaut D. Fusobacteriumnucleatum in periodontal health and disease. Curr Issues Mol Biol2011; 13: 25-36 [PMID: 21220789]. 被引量:1
  • 7Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, GroteVA, Tjneland A, Dahm CC, Overvad K, Jenab M, Fedirko V,Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Kaaks R,Boeing H, Foerster J, Trichopoulou A, Lagiou P, Trichopoulos D,Sacerdote C, Sieri S, Palli D, Tumino R, Panico S, Siersema PD,Peeters PH, Lund E, Barricarte A, Huerta JM, Molina-Montes E,Dorronsoro M, Quir JR, Duell EJ, Ye W, Sund M, Lindkvist B,Johansen D, Khaw KT, Wareham N, Travis RC, Vineis P, Buenode-Mesquita HB, Riboli E. Plasma antibodies to oral bacteria andrisk of pancreatic cancer in a large European prospective cohortstudy. Gut 2013; 62: 1764-1770 [PMID: 22990306 DOI: 10.1136/gutjnl-2012-303006]. 被引量:1
  • 8Michaud DS. Role of bacterial infections in pancreatic cancer.Carcinogenesis 2013; 34: 2193-2197 [PMID: 23843038 DOI:10.1093/carcin/bgt249]. 被引量:1
  • 9Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N.Induction of experimental ulcerative colitis by Fusobacteriumvarium isolated from colonic mucosa of patients with ulcerativecolitis. Gut 2003; 52: 79-83 [PMID: 12477765]. 被引量:1
  • 10Minami M, Ando T, Okamoto A, Sasaki N, Ohkura T, Torii K,Hasegawa T, Ohta M, Goto H. Seroprevalence of Fusobacteriumvarium in ulcerative colitis patients in Japan. FEMS Immunol MedMicrobiol 2009; 56: 67-72 [PMID: 19484811]. 被引量:1

共引文献62

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部